Paloma Partners Management CO Biogen Inc. Transaction History

Paloma Partners Management CO

$3.28 Billion
Q2 2024

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$212.02 - $267.71 $35,407 - $44,707	167 Added 315.09%	220 $47,000
Q4 2023 Feb 14, 2024	BUY	$222.59 - $267.94 $11,797 - $14,200	53 New	53 $13,000
Q4 2022 Feb 14, 2023	BUY	$252.44 - $306.72 $254,207 - $308,867	1,007 New	1,007 $278,000
Q2 2022 Aug 15, 2022	BUY	$187.54 - $223.02 $120,775 - $143,624	644 Added 58.23%	1,750 $357,000
Q1 2022 May 16, 2022	SELL	$193.77 - $244.14 $61,037 - $76,904	-315 Reduced 22.17%	1,106 $233,000
Q4 2021 Feb 14, 2022	SELL	$223.92 - $287.77 $1.4 Million - $1.8 Million	-6,242 Reduced 81.46%	1,421 $341,000
Q3 2021 Nov 15, 2021	BUY	$282.99 - $369.05 $2.17 Million - $2.83 Million	7,663 New	7,663 $2.17 Million
Q2 2021 Aug 16, 2021	SELL	$259.0 - $414.71 $473,970 - $758,919	-1,830 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$242.95 - $284.63 $444,598 - $520,872	1,830 New	1,830 $512,000
Q4 2020 Feb 16, 2021	SELL	$236.26 - $355.63 $7.8 Million - $11.7 Million	-33,018 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$264.77 - $305.71 $986,003 - $1.14 Million	3,724 Added 12.71%	33,018 $9.37 Million
Q2 2020 Aug 14, 2020	BUY	$258.66 - $342.55 $6.95 Million - $9.21 Million	26,888 Added 1117.54%	29,294 $7.84 Million
Q1 2020 May 15, 2020	SELL	$268.85 - $341.04 $7.22 Million - $9.15 Million	-26,839 Reduced 91.77%	2,406 $762,000
Q4 2019 Feb 14, 2020	SELL	$220.06 - $304.07 $17.6 Million - $24.3 Million	-79,766 Reduced 73.17%	29,245 $8.68 Million
Q3 2019 Nov 14, 2019	BUY	$217.44 - $243.88 $12.6 Million - $14.1 Million	57,803 Added 112.88%	109,011 $25.4 Million
Q2 2019 Aug 14, 2019	BUY	$219.29 - $241.72 $3.53 Million - $3.9 Million	16,120 Added 45.94%	51,208 $12 Million
Q1 2019 May 15, 2019	BUY	$216.71 - $338.96 $7.38 Million - $11.5 Million	34,043 Added 3257.7%	35,088 $8.29 Million
Q4 2018 Feb 14, 2019	SELL	$278.5 - $352.75 $30.5 Million - $38.6 Million	-109,441 Reduced 99.05%	1,045 $314,000
Q3 2018 Nov 14, 2018	BUY	$293.51 - $383.83 $29.3 Million - $38.4 Million	99,969 Added 950.55%	110,486 $39 Million
Q2 2018 Aug 14, 2018	SELL	$257.52 - $306.91 $788,526 - $939,758	-3,062 Reduced 22.55%	10,517 $3.05 Million
Q1 2018 May 15, 2018	BUY	$260.13 - $367.91 $2.76 Million - $3.91 Million	10,621 Added 359.06%	13,579 $3.72 Million
Q4 2017 Feb 14, 2018	SELL	$307.64 - $344.58 $2.91 Million - $3.25 Million	-9,444 Reduced 76.15%	2,958 $942,000
Q3 2017 Nov 14, 2017	BUY	$281.15 - $329.69 $3.49 Million - $4.09 Million	12,402	12,402 $3.88 Million

Others Institutions Holding BIIB

# of Institutions

1,018

Shares Held

128M

Call Options Held

1.22M

Put Options Held

1.4M

Vanguard Group Inc Valley Forge, PA

16.6M
Shares

$2.88 Billion
0.08% of portfolio
Primecap Management CO Pasadena, CA

16.3M
Shares

$2.84 Billion
2.78% of portfolio
Black Rock Inc. New York, NY

14.5M
Shares

$2.53 Billion
0.08% of portfolio
State Street Corp Boston, MA

7.1M
Shares

$1.23 Billion
0.07% of portfolio
T. Rowe Price Investment Management, Inc. Baltimore, MD

5.68M
Shares

$987 Million
0.83% of portfolio

View Full List

About BIOGEN INC.

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $25B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

More about BIIB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Paloma Partners Management CO, based on Form 13F filings with the SEC.

News

Stay updated on Paloma Partners Management CO with notifications on news.

Account